What is Evofem?
Evofem Biosciences, Inc. is dedicated to commercializing pioneering products designed to meet the significant unmet needs within women's sexual and reproductive health. The company's mission is driven by a passionate commitment to addressing women's critical concerns and serving markets that have historically lacked adequate choices. By focusing on innovation and faster development cycles, Evofem aims to provide superior alternatives for women seeking better health solutions.
How much funding has Evofem raised?
Evofem has raised a total of $154.8M across 6 funding rounds:
Private Equity
$25M
Series C
$20.6M
Series D
$25M
Other Financing Round
$80M
Stock Offering
$3.3M
Private Equity
$925K
Private Equity (2009): $25M with participation from Undisclosed
Series C (2012): $20.6M led by AMOREPACIFIC US, Alta Partners, RMI Partners, and RUSNANO
Series D (2016): $25M supported by Woodford Investment Management
Other Financing Round (2019): $80M featuring PDL, Woodford Investment Management, and Invesco Asset Management
Stock Issuance/Offering (2024): $3.3M backed by Aditx
Private Equity (2025): $925K, investors not publicly disclosed
Key Investors in Evofem
Woodford Investment Management
Woodford Investment Management is a financial services firm that was involved in managing various investment funds. The company has faced regulatory challenges and has seen changes in management for its funds, with new investment managers appointed for some of them. Their intended clients include investors looking for managed investment solutions.
Invesco Asset Management
Invesco Ltd. is a publicly owned investment manager providing services to retail and institutional clients. The firm manages separate client-focused equity and fixed income portfolios and launches various mutual funds and exchange-traded funds.
AMOREPACIFIC US
Amorepacific is a South Korean beauty and cosmetics company, focusing on skincare, haircare, and makeup products.
What's next for Evofem?
The substantial enterprise-level backing and recent strategic investment position Evofem for accelerated expansion and market penetration. This capital infusion is expected to fuel further research and development, enhance commercialization efforts for existing products, and potentially support the introduction of new innovations. The company's focus on a high-need area within women's health suggests a strategic trajectory aimed at capturing a significant market share and establishing itself as a leader in reproductive health solutions. Future developments will likely involve scaling operations and broadening access to their product portfolio.
See full Evofem company page
